IRCT20180815040801N1已完成1 期
Assessment of Tolerability, Response and Complications of Capecitabin added to Cisplatine for Concurrent Chemoradiation of Muscle Invasive Bladder Cancer
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Patients with muscle invasive bladder cancer (T2 to T4a)
- •TCC pathology
- •Patient's refusal of radical cystectomy or not being candidate to do that due to medical comorbidities
- •Referred by an urologist for concurrent chemoradiation of bladder cancer
排除标准
- •Hydronephrosis that does not resolve with usual treatments
- •Lymphatic or distant metastasis
- •PLT<80,000
研究者
相似试验
尚未招募
不适用
A study evaluating the effect of cortical magnetic stimulation in patients with schizophreniaCTRI/2020/04/024625All India Institute of Medical Sciences New Delhi
Unknown
2 期
Comparative Assessment of Tolerability, Efficacy and Safety of Combination of Compound CDRI 80/574 and Atorvastatin versus Atorvastatin in subjects with HyperlipidemiaCTRI/2011/05/001761Cadila Pharmaceuticals Ltd56
进行中（未招募）
2 期
[M16-109] A Study Evaluating Tolerability and Efficacy of Navitoclax Alone or in Combination With Ruxolitinib in Participants With Myelofibrosis (REFINE)MyelofibrosisJPRN-jRCT2041210029Okubo Sumiko15
进行中（未招募）
不适用
Evaluation de la tolérance et de l’acceptabilité de la Rasagiline dans le traitement de la maladie de Parkinson au stade précoce - ACTORMaladie de Parkinson idiopathique au stade précoceMaladie de Parkinson, numéro de classification MedDRA 10061536EUCTR2007-007397-28-FRQualissima
已完成
不适用
To check for acceptance of midazolam and lignocaine through nasal routeCTRI/2020/05/025073Dr Bhavana I60